Registered entities
Fog Pharmaceuticals, Inc
Reg. No. 47-4505725Belgium
Innovation
13 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 581 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 10 |
Social engagement
Social engagement: 19K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
27 investors on record; lead investors include 6 Dimensions Capital, Google Ventures, Deerfield, Nextech Invest.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 48% |
| Private equity | 3 | 11% |
| Bank & private debt | 3 | 11% |
| Other / undisclosed | 8 | 30% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
31 Mar 2026 · Senior Director, Clinical Pharmacology & Pharmacometrics (CPP)
Based on job postings tracked across public sources.
Recent activity
16 Jun 2026
Milestone
regulatory
10 Jun 2026
Milestone
regulatory
18 May 2026
Partnership
Regeneron Pharmaceuticals